Edward M. MD Kaye - Director at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
STOK on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Edward M. MD Kaye - trading volume in the past year for Stoke Therapeutics, Inc.

Holdings reported by Edward M. MD Kaye for Stoke Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 49.1K $1.47M $30.00 Oct 8, 2025 Direct
Restricted Stock Units 0 $1.19M $8.27 Sep 4, 2025 Direct Common Stock
Performance Stock Units 26.3K $341K $12.99 Aug 14, 2025 Direct Common Stock
Restricted Stock Unit (RSU) 4.32K $52.1K $12.07 Dec 1, 2024 Direct Common Stock
Stock Option (Right to Buy) 543K Oct 8, 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 37.5K Sep 4, 2025 Direct Common Stock

Transactions reported by Edward M. MD Kaye for Stoke Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.